Background and Importance Trastuzumab associated with chemotherapy (platinum and
fluoropyrimidine) is the standard first-line treatment in HER2-positive advanced …

Background Pegylated liposomal doxorubicin (PLD) is indicated in ovarian cancer patients
who have failed firstline platinum based chemotherapy. Currently, there are no clinical or …

Background Certain drugs that need special follow-up are dispensed from hospital
pharmacies in some countries. Due to the increasing number of drugs included in these …

Background The addition of trastuzumab to chemotherapy (cisplatin and fluoropyrimidine)
significantly improved overall survival without compromising safety in patients with HER2 …

Background To date, there has been no phase III trial to establish the optimal duration of first-
line chemotherapy for patients with advanced gastric cancer (AGC): limited treatment …

Background Pegylated liposomal doxorubicin (PLD) can be used for the treatment of
advanced ovarian cancer in women who have failed a first-line platinum-based …

Background There is neither consensus on firstline chemotherapy for advanced gastric
cancer (AGC) nor new drugs or schemes approved in recent years. Purpose To evaluate the …

Background Fampridine has been approved for improvement in walking capacity in adult
multiple sclerosis (MS) patients with an Expanded Disability Status Scale (EDSS) score of 4 …

Background There is no one regimen considered standard for advanced gastric cancer.
Platinum and fluoropyrimidine are the most consolidated for use as firstline palliative …

Background There is currently no consensus for firstline chemotherapy in patients with
advanced gastric cancer (AGC), not eligible to receive trastuzumab. Purpose To evaluate …